Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TACVAC

K-Number: K153459 · 2016-01-28

ApplicantAthena Gtx
Decision Date2016-01-28
Product CodeBTA
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

TACVAC is a medical device manufactured by Athena Gtx. It received FDA 510(k) clearance on 2016-01-28 under approval number K153459. The device is classified under product code BTA. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TACVAC?

TACVAC is a medical device that received FDA 510(k) clearance on 2016-01-28. It is manufactured by Athena Gtx. The 510(k) number is K153459.

When was TACVAC approved by the FDA?

TACVAC received FDA 510(k) clearance on 2016-01-28, under approval number K153459.

What company makes TACVAC?

TACVAC is manufactured by Athena Gtx.

What is the FDA product code for TACVAC?

The FDA product code for TACVAC is BTA.

Other Devices by Athena Gtx

K160582WiCap K173203Athena GTX Device Management Suite (ADMS) Software K191989WVSM (Wireless Vital Signs Monitor) RWC + miniCap

Related Devices (Code: BTA)

K161002Aprima Smartesis Centesis PumpCook Incorporated K153663Vario 8/18/ciMedela AG K170533Model 330 Multifunction AspiratorZOLL Medical Corporation K180863FORA NAS100 Electronic Nasal Aspirator, Electronic Nasal AspiratorTaidoc Technology Corporation K181667Thoraguard SystemCentese, Inc. K180606SOMAVAC DeviceSomavac Medical Solutions, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑